Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. labmaster lucia

LABMASTER LUCIA

Labmaster Lucia - revolutionizing blood diagnostics with rapid accurate low-cost point-of-care tests

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 LABMASTER LUCIA project word cloud

Explore the words cloud of the LABMASTER LUCIA project. It provides you a very rough idea of what is the project "LABMASTER LUCIA" about.

founded    16    antibodies    oy    distributor    2kg    costly    critical    generation    asia    public    revenue    medical    secured    lessen    created    electrons    commercialisation    1985    reduce    patented    asian    aecl    options    staff    speed    hot    expert    hard    site    2023    six    simultaneous    23    priced    distributors    tests    labmaster    ranges    health    scientific    hydrated    lucia    medium    fraction    laboratory    below    antibiotic    innovations    cecl    spending    signal    bypass    17    leader    instrument    sold    instruments    cathodic    blood    sell    small    limited    prescription    miniaturize    fi    overcomes    immobile    interference    diagnostics    precision    generating    point    disturbance    diagnostic    perform    vitro    poc    10m    medtech    device    patient    cartridge    cartridges    treatment    commercialized    291m    harnesses    minutes    electrochemiluminescence    fast    segment    slow    breakthrough    care    50    anywhere    mobile    hospitals    accurate    prepare    targetted    improves    fluid    finland    compact    clinics    media    expensive    ivd    creation   

Project "LABMASTER LUCIA" data sheet

The following table provides information about the project.

Coordinator		 LABMASTER OY 

Organization address
address: FISKARSINKATU 11
city: TURKU
postcode: 20750
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Finland [FI]
 Project website http://labmaster.fi/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-02-01   to  2018-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LABMASTER OY FI (TURKU) coordinator 50˙000.00

Map

 Project objective

The Labmaster Lucia is the next generation diagnostics instrument for point-of-care blood tests. The compact device harnesses the breakthrough Cathodic ElectroChemiLuminescence (CECL) method to increase diagnostic speed and precision. Using the Lucia, medical staff can perform in vitro diagnostics (IVD) anywhere and get accurate results within five minutes at a fraction of the cost of existing methods. Blood diagnostics are critical for patient treatment, but current options are slow and costly due to large IVD immobile equipment. IVD devices are hard to miniaturize due to the scientific problem of sample medium signal interference. Labmaster's patented CECL technology overcomes signal disturbance problems using hydrated hot electrons that bypass fluid media, enabling the creation of small, mobile IVD devices for fast on-site diagnostics. Using CECL, Labmaster has created two products: (1) The Lucia, a 2kg POC IVD unit; (2) Test cartridges with antibodies to test a range of medical conditions. The Lucia improves on current FI and AECL IVD methods which require large expensive laboratory equipment, or have limited testing ranges. The Lucia has a wider testing range and allows simultaneous tests on one cartridge. It will be priced 50% below the current segment leader. This will reduce public health spending, improve treatment and lessen antibiotic prescription. The Lucia and cartridges will be sold to hospitals and clinics in Europe and Asia via medtech distributors. One Asian distributor is secured, six more will be targetted in this project. Labmaster Oy was founded in Finland in 1985, has 17 expert staff, and already commercialized 16 diagnostic innovations. It aims to sell 23,000 Lucia instruments and 10M cartridges by 2023, generating €291M in revenue. This project will prepare for the development of a new cartridge to test for a common condition, and prepare for commercialisation.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LABMASTER LUCIA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LABMASTER LUCIA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

ClearRing (2018)

An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.

Read More  

JUMPAIR (2018)

Decubitus Ulcers Diseases Diagnoses by means of Smart ICT Anti-Decubitus System based on known Ulcers Activity Biomarkers

Read More